Vanguard Group Inc Summit Therapeutics Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
146Shares Held
66.2MCall Options Held
1.05MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$464 Million2.41% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$158 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$82.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$59.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.04MShares$40.8 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.02B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...